25. Aldington S, Bonnerjea J. Scale-up of monoclonal antibody purification processes. J Chromatogr B. 2007;848:64–78.
26. Zhou J, Tressel T. Basic concepts in Q membrane chromatography for large-scale antibody production. Biotechnol Progr.
2006;22:341-349.
27. Warner WM, Nochumson S. Rethinking the economics of chromatography. BioPharm Int. 2003 Jan; 58–60.
28. Jagschies G, O'Hara A. Debunking downstream bottleneck myth. Gen Eng News. 2007 Aug;27(14).
29. Thiel KA. Biomanufacturing, from bust to boom... to bubble? Nat Biotechnol. 2004;22:1365–1372.
30. Smith M. An evaluation of Protein A and non-Protein A methods for the recovery of monoclonal antibodies and considerations
for process scale-up. Proceedings of scaling-up of biopharmaceutical products. 2004 Jan 26–27; Amsterdam.
31. Sofer G, Chirica LC. Improving productivity in downstream processing, Pharm Tech Eur. 2007 Apr.
32. Davies J, Smith, M, Bonnerjea J. The influence of scale of operation on purification process design. Proceedings of 154th
Society for General Microbiology Meeting, 2004 29 March–2 April, Bath, UK.
33. Thömmes J, Etzel M. Alternatives to chromatographic separations. Biotechnol Progr. 2007;23(1):42–45.
34. Knudsen H, Fahrner R, Xu Y, Norling L, Blank G. Membrane ion-exchange chromatography for process-scale antibody purification.
J Chromatogr A. 2001;907:145–154.
35. Boi C. Membrane adsorbers as purification tools for monoclonal antibody purification. J Chromatogr B. 2007;848:19–27.
36. Lim JAC, Sinclair A, Kim DS, Gottschalk U. Economic benefits of single use membrane chromatography in polishing: A cost
of goods model. BioProcess Int. 2007;5(2):60–64.
|
